According to some statistics, only 40% of women regularly achieve climax during sex as opposed to men who attain orgasm 98% of the time."  And, according to some experts, about 70% of women are not having orgasms. Women's turn is overdue and VI-GEL™ has arrived on the scene to improve the quality and quantity of womens orgasms and overall sex life satisfaction.

VIGEL, Inc. is proud to announce the release of its namesake product VIGEL™.  VIGEL™ is the first product of its type exclusively for women to hit the mass-market. Many are saying VIGEL marks the first time women have had their own version of that little blue pill. VIGEL works very much by stimulating the circulation in the female sexual organs. However, VIGEL is an all natural product that contains no drugs and requires no doctor's prescription.

VIGEL is a topical gel that contains L-Arginine. The 1998 Nobel Prize for Medicine and Physiology was awarded for the discovery of the Nitric Oxide Pathway which many experts believe is the basis for clitoral erection. Recent double-blind, placebo-controlled studies suggest L-Arginine causes the production of Nitric Oxide which in turn improves clitoral sensitivity as well as frequency of orgasm. VIGEL also contains menthol which gives women a pleasant tingle.

Countless women have praised VIGEL's effectiveness with comments like "My husband and I were only having sex once a month at most. Now since I started using VIGEL, we're making love almost every day" and "VIGEL is great. I've never found a product that makes sex so fulfilling." The reason for the strong, positive response is that VIGEL works! In one double-blind, placebo-controlled study, 93 women, ages 22-73, enrolled as participants lacking sexual desire. 46 received L-Arginine and 47 received a placebo. At the end of four weeks, 62 percent of the active group reported significantly improved satisfaction with their overall sex life and 64 percent reported an improvement in their level of sexual desire.

Another study was a randomized, double-blind, placebo-control led, three-way crossover clinical trial. The patients were post-menopausal women. The results showed a rapid and significant increase in Vaginal Pulse Amplitude Response (meaning the subject's degree of sexual stimulation) after the L-Arginine was administered as compared to the placebo group.

The sales of VIGEL have been astounding. Production has been greatly increased to meet demand. There is an enormous market for this product because, according to some statistics, only 40% of women regularly achieve climax during sex as opposed to men who attain orgasm 98% of the time."

VIGEL Inc. is marketing VIGEL through national magazines such as GLAMOUR,  SELF, and COSMOPOLITAN,  as well as on radio and television.